Skip to main content
Fig. 2 | Chinese Medicine

Fig. 2

From: Cerebralcare Granule® enhances memantine hydrochloride efficacy in APP/PS1 mice by ameliorating amyloid pathology and cognitive functions

Fig. 2

The scheme of experiment and MWM test. a The scheme of experiment to determine the effect of CG on APP/PS1 memory loss. bf MWM test was conducted on APP/PS1 mice. b The representative traces on the last day during acquisition phase. c Escape latency trend for six consecutive days. d Escape latency on the sixth day. e Times of passing through platform. f Time in the target quadrant. ^ P < 0.05, ^^ P < 0.01, ^^^ P < 0.01 vs. WT group; * P < 0.05, ** P < 0.01, *** P < 0.01 vs. Tg group; # P < 0.05, ## P < 0.001, ### P < 0.001, vs. Mm group, & P < 0.05, && P < 0.001, &&& P < 0.001, vs. CG group (n = 10)

Back to article page